ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LLAI Lunglife Ai Inc

9.50
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lunglife Ai Inc LSE:LLAI London Ordinary Share ORD USD0.0001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.50 9.00 10.00 9.50 9.50 9.50 0.00 07:34:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Lunglife Ai Share Discussion Threads

Showing 76 to 94 of 100 messages
Chat Pages: 4  3  2  1
DateSubjectAuthorDiscuss
19/11/2024
11:01
That was an encouraging update today .
I added a few .

ohisay
23/8/2024
01:58
Investor Meet ..
Lets see if they can capitalise on this development in the next six months ,



MolDX, which oversees the evaluation of molecular diagnostics for Medicare, was considering additional evidence that could broaden the scope of coverage, presenting further opportunities for LungLife.
With the LCD in place, LungLife said it had successfully secured the three key components necessary for the commercial launch of LungLB - a billing code, a set price, and now Medicare coverage.
That, it said, paved the way for wider adoption of the test by healthcare providers, facilitating earlier and more accurate lung cancer diagnoses for patients with indeterminate lung nodules.
“Having a local coverage determination (LCD) for risk stratification testing of indeterminate lung nodules represents a key opportunity for our company,” said chief executive officer Paul Pagano.
“It enables us to progress to the next stage of commercialisation by providing a clear pathway to make our innovative LungLB test more accessible and reimbursable under Medicare.

“This supports our commitment to enabling 80% of lung cancer to be detected early.”

ohisay
19/8/2024
10:18
my buy and many more are showing as sells.

I think things will get better for the company as it should make decent revenues at over $2000 for each lung test.

joseph moran
17/8/2024
07:05
Yes this is getting more interesting by the day. Maybe this is one small pharma company that will make it into sales and profits, before being taken away by the big boys !!! one way or another.
parsons4
06/4/2024
01:39
Investor Meet recording .
Quite an impressive Road map for commercialisation in the next 12 months ..worth keeping an eye on .

ohisay
25/3/2024
11:24
Hopefully buyers returning
joseph moran
12/3/2024
12:25
Buy showing 28.40 time 13.45 Wonder if it means yesterday as it is 12.24 currently.Hopefully buyers returning after days of falls
joseph moran
11/3/2024
13:25
The spread is really small at the moment. The system will not let me sell, the traders have to execute the order.
However I can buy for £0.289 the quoted sell price is £0.284

Never known such a small spread on this stock.

joseph moran
07/3/2024
16:36
PI's look like they are out of the loop .Unless that changes the share price is fathomless.
ohisay
07/3/2024
15:53
Shares heading South as well, not great signs....happy to stay on side lines until material progress that will benefit shareholders
qs99
07/3/2024
14:50
They are asking in their resolutions the authority to issue 100m shares as they deem fit .
Current shares in issue is 25m rising to 30m after this placing.
Why such a large increase ?

The resolutions to be proposed at the Special Meeting are:
(a) Resolution 1: To increase the number of Common Shares that the Company is authorised to issue to 100,000,000 Shares in order to accommodate the Placing and Subscription and to provide appropriate headroom to allow for the issue of Common Shares following the Placing and Subscription, and also to generally authorise the Company to allot and issue Common Shares pursuant to the Placing and Subscription.

That's a bit of a Red Flag for me .
As is the super low buying from the Directors in the placing .
As Ive really no idea wtf is going on I'm out FWIW.

ohisay
05/3/2024
12:51
Doh, sorry mate, literally went through this mornings RNS only, village I know, will take a look.
Cheers

qs99
05/3/2024
09:20
Very little info ??

2. Background to, and reasons for, the Fundraising

There's plenty of information there in last nights RNS .

ohisay
05/3/2024
08:30
Indeed...market was flagging something was up IMO!

Wonder how far this will take them as v. little info

qs99
04/3/2024
19:12
Well that could have been worse 15.7% discount on a £1.8m raise funded to April 2025. When hopefully the market has recovered somewhat
hatfullofsky
26/1/2024
08:33
Thnks ohisay

Chart looking sickly, I'll wait and see, but as you say, I lilke the tech & market opp....DYOR

qs99
24/1/2024
09:01
Bit of a decline this am....am waiting for a good entry point...
qs99
18/1/2024
17:30
Will this need a new fund raising soon do you think?
qs99
17/1/2024
16:07
Sorry wrong thread was meant for OBD
hatfullofsky
Chat Pages: 4  3  2  1

Your Recent History

Delayed Upgrade Clock